Grifols Egypt for Plasma Derivatives (GEPD) Tech Stack

Plasma derivatives manufacturing and donor network for Egyptian healthcare

Pharmaceutical Manufacturing Cairo 501–1,000 employees Partnership

GEPD operates a public-private joint venture between the Egyptian Government and Grifols to manufacture plasma-derived medicines domestically. The tech stack is heavily pharma-compliance-focused (SAP QM, Veeva, SCADA, PLC, CMMS) with active adoption of SAP Treasury, signaling operational maturity across manufacturing and finance. Pain-point clustering around GMP/cGMP compliance, donor retention, and deviation management reflects the core scaling challenge: ramping a 20-center donor network while maintaining manufacturing quality at 1M liters/year capacity.

Tech Stack 18 technologies

Core StackSAP Siemens LinkedIn Microsoft Office SAP Treasury Excel Word PowerPoint Visio CCTV PLC SAP QM Veeva SAP PM SCADA HMI CAD CMMS

AdoptingSAP Treasury

What Grifols Egypt for Plasma Derivatives (GEPD) Is Building

◆Challenges

Ensuring cgmp compliance
Compliance with regulations
Maintaining gmp compliance
Optimizing donor recruitment and retention
Reducing donor complaints
Maintaining plasma quality
Increasing donor retention
Managing deviations and corrective actions
Implementing capa system
Reducing equipment downtime

▲Active Projects

Sop editing for donor center processes
Implementation of sap treasury (trm) modules
Donor retention and loyalty program implementation
Policy and sop revision for source plasma quality systems
Sop review and development
Crisis management and emergency response operations
Digitalization initiatives related to treasury operations
Compliance program implementation
Donor satisfaction survey analysis
Donor satisfaction surveys

Hiring Activity

Accelerating110 roles · 75 in 30d

Department

Healthcare

Ops

Manufacturing

Logistics

Engineering

Finance

Quality

Support

Seniority

Mid

Junior

Senior

Manager

Lead

Director

Notable leadership hires: Facility Lead

Company intelligence

Find more companies like Grifols Egypt for Plasma Derivatives (GEPD) by tech stack, pain points and active projects

Get started free

About Grifols Egypt for Plasma Derivatives (GEPD)

GEPD is a joint venture between Egypt's National Service Projects Organization and Grifols, a global plasma therapeutics company, established to develop local plasma medicine manufacturing and supply. The operation encompasses 20 planned plasma donation centers across Egypt, plus a 105,000-square-meter manufacturing complex in the administrative capital's medical city, with fractionation, purification, and fill-and-finish facilities. Current capacity reaches 1 million liters of plasma annually, with room to double. The company employs 501–1,000 people across healthcare, operations, manufacturing, logistics, engineering, finance, and quality functions, with active hiring weighted toward mid-level staff and new healthcare roles.

HeadquartersCairo

Company Size501–1,000 employees

Hiring MarketsEgypt

Frequently Asked Questions

What is Grifols Egypt for Plasma Derivatives?

GEPD is a public-private joint venture between Egypt's government (NSPO) and Grifols to manufacture plasma-derived medicines locally. It operates 20 donor centers and a manufacturing facility with 1M liters/year processing capacity.

What technology does Grifols Egypt use?

Stack includes SAP (QM, PM, Treasury), Veeva, SCADA, PLC, Siemens, CAD, and CMMS. Currently adopting SAP Treasury modules for digitalization and compliance.